Dallas, Texas. October 10, 2022:etiraRx's lead drug candidate, ERX-41 has been highlighted in the most recent edition of Oncology Times. In an article entitled "Molecule Targets Vulnerability in Triple-Negative Breast Cancer," Dibash Kumar…
https://etira.life/wp-content/uploads/2022/10/Oncology-thumbnail.jpg661648Ilona Margolishttps://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.pngIlona Margolis2022-10-10 14:45:172023-11-30 12:55:47Oncology Times Highlights ERX-41
Dallas Texas, September 23, 2022. We are pleased to announce that Etira has been selected as a 2022 BioNTX rising star.
The BioNTX iC³ Life Science Summit is a two-day conference, held on September 22-23, 2022 that serves as a forum where…
https://etira.life/wp-content/uploads/2022/09/bio-ntx.jpg661648Ilona Margolishttps://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.pngIlona Margolis2022-09-23 18:41:022023-11-30 12:57:48Etira selected as a 2022 BioNTX rising star
Dallas, Texas. July 7, 2022:
On the cover of the July 2022 issue of Nature cancer is an image of the endoplasmic reticulum within a cell. Image courtesy of Dr. Andrew S. Moore, Janelia Research Campus. Cover Design by Allen Beattie. Highlighted…
https://etira.life/wp-content/uploads/2023/06/nature-cancer-cover-1.jpg743556Ilona Margolishttps://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.pngIlona Margolis2022-07-10 15:30:512023-11-30 12:57:25ERX-41 Paper image selected for Nature Cancer cover
https://etira.life/wp-content/uploads/2022/07/Scientific-Thumbnail.jpg661648Ilona Margolishttps://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.pngIlona Margolis2022-07-01 09:23:172023-11-30 13:02:24Scientific News Media Features the Discovery of ERX-41, the Novel Mechanism of Action and Novel Molecular Target
Oncology Times Highlights ERX-41
NewsEtira selected as a 2022 BioNTX rising star
NewsERX-41 Paper image selected for Nature Cancer cover
NewsScientific News Media Features the Discovery of ERX-41, the Novel Mechanism of Action and Novel Molecular Target
News